Abstract: Embodiments discussed herein facilitate determination of risk of relapse of AML post-transplant. One example embodiment is a method, comprising: accessing a digital whole slide image (WSI) comprising a post-transplant bone marrow aspirate from a patient that has acute myeloid leukemia (AML); segmenting one or more myeloblasts on the digital WSI; extracting one or more features from the segmented one or more myeloblasts; providing the one or more features extracted from the segmented one or more myeloblasts to a trained machine learning model; and receiving, from the trained machine learning model, an indication of a risk of relapse of the AML.